Delivery Order SPE2DB22D2206-SPE2DB24FJS30

Award Date 8/8/24
Potential Completion Date 8/29/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of various medical products and supplies. The contract has a ceiling value of $1,182.71 and a period of performance through September 18, 2024. The contract is a firm fixed-price, delivery order type with no set-aside designation. It is associated with a larger Indefinite Delivery Contract (IDC) the DLA has with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) and has a ceiling value of $1,182.71. The contract is a delivery order (SPE2DB24FT79Z) awarded on April 23, 2024, with a completion date of May 14, 2024. The contract is for the supply of 4564376597 ! XDEMVY 0.25% DROP 10ML, a medical product, on a firm fixed-price basis. The contract does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of medical products. The contract, valued at $1,182.71, is for the delivery of a pharmaceutical product described as "4565470611 ! XDEMVY 0.25% DROP 10ML". The contract has a completion date of September 6, 2024 and was awarded on August 15, 2024. The contract type is Firm Fixed Price, and it does not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,623.74 and a period of performance through April 29, 2025. It is a firm fixed-price contract for the delivery of pharmaceutical and medical products, including medications across various therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $37,582.44 and an ultimate completion date of November 18, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation, for the provision of various pharmaceutical products and medical supplies to support military healthcare...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of a medical product described as "4565331243 ! XDEMVY 0.25% DROP 10ML." The contract has a firm fixed price of $1,182.71 and a completion date of August 23, 2024. It is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,355.40 and a performance period through May 2, 2025. It is a firm fixed price contract for the delivery of pharmaceutical and medical supplies, including medications across various therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a variety of pharmaceutical and medical products. The contract has a ceiling value of $32,759.22 and a performance period through July 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $171,715.39 and a performance period through May 2, 2025. It is a firm fixed-price contract for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of a variety of pharmaceutical products and medical supplies. The contract has a firm fixed price and a ceiling value of $10,128.78, with an ultimate completion date of June 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJS30
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of pharmaceutical products. The contract has a ceiling value of $1,182.71 and runs through August 29, 2024. It is a firm fixed price contract for the delivery of various medications, including a "4565393346 ! XDEMVY 0.25% DROP 10ML" product. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide essential medical commodities to military treatment facilities, veterans' hospitals, and other government healthcare providers. This specific award is part of a larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of pharmaceutical and medical supplies from the company.

Generated 11/7/24, 9:11 AM